An expressive writing randomised controlled trial with colorectal cancer patients: A test of the underlying mechanism

Phase 1

Active, not recruiting

• Conditions: Colorectal cancer; Cancer - Bowel - Back passage (rectum) or large bowel (colon)

• Registration Number: ACTRN12606000204549
• Lead Sponsor: Peter MacCallum Cancer Centre

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2006-05-29
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 160

Inclusion Criteria

(a) colon or rectal cancer (Dukes stage A, B or C), (b) completed all cancer treatment within last 4 weeks, (c) can read/write English.

Exclusion Criteria

(a) has metastatic disease, (b) has recurrent colorectal cancer, (c) previous cancer diagnosis of any type, (d) psychiatric illness (not related to cancer diagnosis).

Study & Design

• Study Type: Interventional
• Study Design: Not specified